El Miedany, Yasser http://orcid.org/0000-0002-4543-692X
El Hadidi, Khaled http://orcid.org/0000-0002-3134-7264
El Menyawi, Manal Mohamed
El Gaafary, Maha http://orcid.org/0000-0002-3948-3826
Abdel-Nasser, Ahmed http://orcid.org/0000-0002-2614-4868
Abdel Azim, Atef http://orcid.org/0000-0003-1103-1286
Hassan, Waleed http://orcid.org/0000-0002-3238-6804
Mortada, Mohamed http://orcid.org/0000-0002-7198-9878
Tabra, Samar Abd Alhamed http://orcid.org/0000-0001-6414-5602
Saber, Sally http://orcid.org/0000-0001-8162-4699
Amer, Ibrahim http://orcid.org/0000-0003-3778-8826
Shaker, Engi Seif E. http://orcid.org/0000-0003-3945-5304
Maria, Dina http://orcid.org/0000-0002-5838-7549
Abu-Zaid, Mohamed Hassan http://orcid.org/0000-0001-8436-8598
Article History
Received: 22 November 2023
Accepted: 5 January 2024
First Online: 20 February 2024
Declarations
:
: This study was performed in accordance with the Helsinki Declaration. This was a multistep process that followed the “Clinical, Evidence-based, Guidelines” (CEG) initiative protocol (ethical approval code: 34842/8/21, ethical board Tanta University) aiming at setting up an actionable clinical gold standard for Treat-to-Target management of rheumatic and bone diseases.
: Not applicable.
: The authors declare that Mohammed Hassan Abu-Zaid is the associate editor of the Egyptian Rheumatology and Rehabilitation, and Waleed Hassan, Mohammed Mortada, and Yasser El Miedany are from the editorial board of the journal.